ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_223259_177 # 193806 # 195755 # 1 # ID=8_177;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.417	k141_223259_177	193806	195755	+	Strict	300	302.753	poxtA	34.85	3004470	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGATATTAGCATGCAATCATATTTCAAAGGCATTTGCAGACGAAACCGTTTTGTCAGATGCTGTTTTTCATATAAATGAAGGTGAACGCGCTGCCATCGTAGGAATTAACGGTGCCGGCAAAACAACACTGCTGCGAATCATTGTCGGTGAACTTCCGGCAGATTCCGGTGAAATTGTAACAGCTAAAGGAAGTACCATCGGCTATCTCCCACAGCAGCAGGGATATCACTCAGACAAAACAATTTATGAGGAATTATTGGCTGTCAAATCGGATGTCATTGAAATGGACGAAAAAATCCGTGCAATGGAGCAGCAAATGACAACTTTAGAAGGTGCCGAATTAGAGCGTGTGTTAAACCAATACCATAAGCTGCAAACGGCTTTTGAAGATGGTGAAGGATATACTTACAAAAGCAAAGTTCTCGGCGTCATTAACGGTCTTGGCTTTCGCGGAGAAGCGATGCACCAGTGCATCAACAATCTCTCCGGTGGACAAAAAACAAGGGTTGCTCTTGGTAAACTTCTGTTATCAGAACCGGACTTATTGTTGATGGATGAGCCTACAAACCACTTAGATTTGGAATCCGTGCGCTGGCTGGAAAACTATTTAAACGGTTACAAGGGGAGTGTCTTAGTTGTCTCTCATGACCGCTTTTTCATCGACCGCATCGCCGAGAAAATTATTGAAATTGACCACGGCAAAGTAATGACTTTTACCGGTGACTATACCAGTTATTCCGAAAAAAAGGAAAAATTACGCGAGGAAATGATTCACCGCTACTATAACCAGCAGCAGGAAATCAAACACCAGGAAGCTGTCATCCAGAAATTAAAATCCTTTAACCGTGAAAAGTCAATTCGCCGTGCGGAAAGCCGTGAAAAAATGTTAGCCAAAATCGAACGTGTAGAAAAGCCGGTGGAATACGAAAAATCACTTTCTCTTTCCCTGACTCCTTCAGTAATCAGTGGAAATGATGTTTTGACGGTCACGGATTTTGCCAAAAGTTTTGGAGAAAACCACTTGTTTGACCATCTTTCCTTTTCAATTAAACGAGGCGAAAAGGTGGCAATTATCGGCAAGAATGGAACCGGCAAAACAACACTTTTAAAATTAATTCAGGGAATGATTCCGGTTGATGAAGGAAGTGCCGTAACCGGCTCTCATGTCGAAATCGGTTACTATGACCAGGAACATCAGATGCTTAACGATGATAAAACCATCTTTGAAGAAATTCAGGATGATTACCCGGATTTAACAAATACAGCAATTCGTAATGTTCTCGCTGCCTTTTTATTTACGGGAGATGATGTTTTTAAACCGATTCATCTTCTCAGCGGTGGTGAAAAAGGTCGTGTATCATTGGCGAAACTGATGCTGTCAAAGGCAAACTTTTTACTCCTTGACGAGCCGACCAACCATTTGGATATTACCTCCAAGGAAATTTTGGAATCCGCAATTAATAAATATGAGGGAACCGTGCTTTACGTCTCGCATGACCGTTATTTTATCAACCGCACCGCCACAAGAATTTTGGATTTAACCGGGCACAAACTGCTCTCCTACAGTGGAAATTATGCGTACTATCTGGAGAAAAAAGATACGGTGGAAAGCCGCTTTTTAACAGATGACGATAAAACCATGCAGACTTCTGCAAAAAAAGATACAAAAGAAGAAGGTAAGCTTGACTGGCAGGAGCAGAAAAAACTGGCAGCGAAAAAGCGAAAAATTGAAAACGAATATCAAAAAACCGAACAAGAAATTGAAGCACTGGAAACGGACATTGCAAATCTTGATGAGGAACTGATGCGTCCGGAATATGCATGCAATGCTCATAAACTAAACGAATTATCAACCGCCCGCGAAGAAAAAGAAACCGCTCTCACTGCCGCTATGGAGCAATGGGAACGGTTAGCCGAACAATTAGAAGAATTTGAAGTTACTGAGTAA	MILACNHISKAFADETVLSDAVFHINEGERAAIVGINGAGKTTLLRIIVGELPADSGEIVTAKGSTIGYLPQQQGYHSDKTIYEELLAVKSDVIEMDEKIRAMEQQMTTLEGAELERVLNQYHKLQTAFEDGEGYTYKSKVLGVINGLGFRGEAMHQCINNLSGGQKTRVALGKLLLSEPDLLLMDEPTNHLDLESVRWLENYLNGYKGSVLVVSHDRFFIDRIAEKIIEIDHGKVMTFTGDYTSYSEKKEKLREEMIHRYYNQQQEIKHQEAVIQKLKSFNREKSIRRAESREKMLAKIERVEKPVEYEKSLSLSLTPSVISGNDVLTVTDFAKSFGENHLFDHLSFSIKRGEKVAIIGKNGTGKTTLLKLIQGMIPVDEGSAVTGSHVEIGYYDQEHQMLNDDKTIFEEIQDDYPDLTNTAIRNVLAAFLFTGDDVFKPIHLLSGGEKGRVSLAKLMLSKANFLLLDEPTNHLDITSKEILESAINKYEGTVLYVSHDRYFINRTATRILDLTGHKLLSYSGNYAYYLEKKDTVESRFLTDDDKTMQTSAKKDTKEEGKLDWQEQKKLAAKKRKIENEYQKTEQEIEALETDIANLDEELMRPEYACNAHKLNELSTAREEKETALTAAMEQWERLAEQLEEFEVTE	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	119.74	gnl|BL_ORD_ID|2577|hsp_num:0	2904		
